Artificial intelligence(AI)is a branch of computer science that develops intelligent machines.In recent years,medicine has been contemplated with this recent modality to aid in the diagnosis of diseases in several spe...Artificial intelligence(AI)is a branch of computer science that develops intelligent machines.In recent years,medicine has been contemplated with this recent modality to aid in the diagnosis of diseases in several specialties,including gastroenterology and gastrointestinal endoscopy.This new technology has superior ability to perform tasks mimicking human behavior and can identify possible pathological alterations,such as pre-malignant lesions and dysplasia,precursor lesions of colorectal cancer(CRC),and support medical decisionmaking.CRC is among the three most prevalent cancer types,and the second most common cause of cancer-related deaths worldwide;in addition,it is a leading cause of death in patients with inflammatory bowel disease(IBD).Patients with IBD tend to have greater inflammatory cell activity in the intestinal mucosa,which can favor cell proliferation and CRC development.AI can contribute to the detection of pre-neoplastic lesions in patients at risk of CRC development,such as those with extensive IBD or when additional CRC risk factors,such as smoking,are present.In fact,AI systems could improve all aspects of care related to both the detection of pre-malignant and malignant lesions and the screening of patients with IBD.In this review,we aimed to show the benefits and innovations of AI in the screening of CRC in patients with IBD.The promising applications of AI have the potential to revolutionize clinical practice and gastrointestinal endoscopy,especially in at-risk patients,such as those with IBD.展开更多
文摘Artificial intelligence(AI)is a branch of computer science that develops intelligent machines.In recent years,medicine has been contemplated with this recent modality to aid in the diagnosis of diseases in several specialties,including gastroenterology and gastrointestinal endoscopy.This new technology has superior ability to perform tasks mimicking human behavior and can identify possible pathological alterations,such as pre-malignant lesions and dysplasia,precursor lesions of colorectal cancer(CRC),and support medical decisionmaking.CRC is among the three most prevalent cancer types,and the second most common cause of cancer-related deaths worldwide;in addition,it is a leading cause of death in patients with inflammatory bowel disease(IBD).Patients with IBD tend to have greater inflammatory cell activity in the intestinal mucosa,which can favor cell proliferation and CRC development.AI can contribute to the detection of pre-neoplastic lesions in patients at risk of CRC development,such as those with extensive IBD or when additional CRC risk factors,such as smoking,are present.In fact,AI systems could improve all aspects of care related to both the detection of pre-malignant and malignant lesions and the screening of patients with IBD.In this review,we aimed to show the benefits and innovations of AI in the screening of CRC in patients with IBD.The promising applications of AI have the potential to revolutionize clinical practice and gastrointestinal endoscopy,especially in at-risk patients,such as those with IBD.
